相关实验视频

Updated: Jan 18, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

动脉样硬化在血液静止和新血管化的背景下 - 目前知识的现状

Urszula Jakobsche-Policht¹, Agnieszka Bronowicka-Szydełko², Rajmund Adamiec³

¹Clinical Department of Angiology and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, Wroclaw, Poland.

Advances in medical sciences

|September 10, 2025

概括

动脉样硬化病原包括内皮功能障碍和葡萄糖损伤. 这篇评论探讨了亲动脉质因子,血液静止,新血管化和表观遗传变化,为潜在的动脉样硬化回归机制提供了见解.

科学领域:

心血管生物学心血管生物学
病变发生学研究病变发生学研究
内皮功能研究研究内皮功能研究.

背景情况:

动脉样硬化是一种由内皮功能障碍驱动的渐进性疾病,通常是由内皮糖损伤引起的.
它的复杂病原包括生物机械因素 (血压,剪切压力) 和生物化学途径 (脂质代谢,单细胞-巨细胞过渡,免疫反应,脂质积累,新血管化和凝血激活).
最近的发现证实了动脉样硬化回归的可能性,但潜在的机制需要进一步阐明.

研究的目的:

介绍有关动脉样硬化病原学的当前知识.
为了强调影响葡萄糖和内皮的亲有风性过程.
突出血液静止,新血管化和动脉样硬化中的表观遗传修饰的作用.

主要方法:

关于动脉样硬化的当前科学知识的文献综述.
对促进病原发生的生物机械和生物化学因素的分析.
专注于内皮葡萄糖的完整性及其在疾病进展中的作用.

主要成果:

内皮功能障碍与葡萄糖损伤有关,是动脉样硬化的主要驱动因素.
包括脂质疾病,炎症和凝血在内的多种因素有助于斑块的发展.
表观遗传变化正在成为动脉样硬化发展和潜在回归的关键因素.

结论:

了解动脉样硬化症的复杂病变发生,特别是葡萄糖和内皮干扰,至关重要.
血液静止,新血管化和表观遗传变化是研究动脉样硬化进展和回归的关键领域.
对这些机制的进一步研究可能会揭示用于逆转动脉样硬化变化的新疗法标.

关键词:

动脉样硬化是一种动脉样硬化.血液静止血液静止血液静止新血管化的新血管化.血小板是血小板的组成部分.oxLDL oxLDL 的意思是什么?

更多相关视频

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

相关概念视频

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Vascular Spasm

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...